Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/25 10:47 | 3/28/25 | LH | Health | Health | Medical Laboratories | Summy Amy B. | NC | O | EVP,CMO | 2 | S | -232 | 235.97 | 0 | -1 | 5 | D | |||||||||||||||
3/31/25 10:39 | 3/28/25 | LH | Health | Health | Medical Laboratories | Schroeder Mark S | NC | O | EVP,P Di | 2 | S.d | -1,941 | 243.43 | 0 | -8 | 5 | D | |||||||||||||||
3/7/25 08:16 | 3/5/25 | LH | Health | Health | Medical Laboratories | Anderson Kerrii B | NC | D | 1 | S | -128 | 255.63 | 0 | -1 | 13 | D | ||||||||||||||||
2/27/25 10:07 | 2/25/25 | LH | Health | Health | Medical Laboratories | Van Der Vaart Sandra D | NC | O | EVP,GC | 1 | S | -330 | 251.30 | 0 | -1 | 2 | D | |||||||||||||||
2/20/25 15:24 | 2/18/25 | LH | Health | Health | Medical Laboratories | Wilkinson Peter J | NC | O | SVP,Chie | 1 | S.d | -348 | 246.10 | 0 | -1 | 2 | D | |||||||||||||||
2/13/25 11:49 | 2/11/25 | LH | Health | Health | Medical Laboratories | Schechter Adam H | NC | DO | P,CEO | 1 | S.d | -1,497 | 244.62 | 0 | -6 | 88 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |